journal article·2022-06-08

Protein-Crowned Micelles for Targeted and Synergistic Tumor-Associated Macrophage Reprogramming to Enhance Cancer Treatment

Jun-Hui Sun, Xiaoling Liang, Manying Cai, Libiao Yan, Zhengju Chen, Lei Guo, Li Jing, Yupeng Wang, Dongfang Zhou

Nano Letters· Volume 22· Issue 11
Publisher page

Abstract

Tumor-associated macrophages (TAMs) are a promising therapeutic target for cancers, but achieving multitarget therapy of TAMs is still challenging. Here, we develop a protein-crowned micelle system for targeted and synergistic TAM reprogramming to enhance cancer treatment. The doxorubicin-loaded micelles with a hemoglobin crown (Hb-DOXM) can bind with endogenous plasma haptoglobin to realize specific M2-type TAM targeting. Under the tumor hypoxic and acidic environments, Hb-DOXM can responsively release O2 and DOX to reduce the recruitment of TAMs by hypoxia remission and release DOX to kill M2-type TAMs and cancer cells. To reprogram TAMs adequately, the TAM-modulating drug celecoxib is further encapsulated (Hb-DOXM@Cel) to repolarize M2-type TAMs. The targeted and synergistic TAM reprogramming by Hb-DOXM@Cel can remodel the tumor microenvironment (TME) to an immunostimulatory microenvironment and augment the antitumor effect of cytotoxic T lymphocyte, thus strongly enhancing the DOX-based chemotherapy. The protein-crowned micelle strategy presents a targeted and synergistic TAM therapy tool for enhanced cancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immune cells in cancer · Phagocytosis and Immune Regulation · Epigenetics and DNA Methylation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Zhejiang Provincial Research Center for Diagnosis and Treatment of Hepatobiliary Diseases Zhejiang University Cancer Center, Hangzhou 310003, People’s Republic of China

Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of China

Department of Ultrasonic Diagnosis, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, People’s Republic of China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province · Guangzhou Science and Technology Bureau · Guangdong Basic and Applied Basic Research Foundation · National Key Research and Development Program of China

References (43)

Show source-provided references
1. 10.1016/j.bbcan.2019.18831410.1016/j.bbcan.2019.188314 ↗
2. 10.1200/JCO.2014.55.413910.1200/JCO.2014.55.4139 ↗
3. 10.3390/cancers1211319710.3390/cancers12113197 ↗
4. 10.1007/978-3-319-78127-3_610.1007/978-3-319-78127-3_6 ↗
5. 10.7150/ijbs.2572010.7150/ijbs.25720 ↗
6. 10.1002/EXP.2021010610.1002/EXP.20210106 ↗
7. 10.1186/s13045-017-0430-210.1186/s13045-017-0430-2 ↗
8. 10.1186/s12929-019-0568-z10.1186/s12929-019-0568-z ↗
9. 10.1038/npjbcancer.2015.2510.1038/npjbcancer.2015.25 ↗
10. 10.1002/adma.20180830310.1002/adma.201808303 ↗
11. 10.1038/nrclinonc.2016.21710.1038/nrclinonc.2016.217 ↗
12. 10.1021/acsnano.1c0670710.1021/acsnano.1c06707 ↗
13. 10.1021/acs.nanolett.7b0119310.1021/acs.nanolett.7b01193 ↗
14. 10.1073/pnas.131219711010.1073/pnas.1312197110 ↗
15. 10.1158/1078-0432.CCR-13-052510.1158/1078-0432.CCR-13-0525 ↗
16. 10.1002/advs.20190003710.1002/advs.201900037 ↗
17. 10.1016/j.biomaterials.2021.12089110.1016/j.biomaterials.2021.120891 ↗
18. 10.1021/acs.nanolett.7b0375610.1021/acs.nanolett.7b03756 ↗
19. 10.18632/oncotarget.1706110.18632/oncotarget.17061 ↗
20. 10.1002/EXP.2021016610.1002/EXP.20210166 ↗
21. 10.1016/j.cell.2014.04.01610.1016/j.cell.2014.04.016 ↗
22. 10.1021/acsnano.7b0546510.1021/acsnano.7b05465 ↗
23. 10.1002/ijc.2352710.1002/ijc.23527 ↗
24. 10.1002/ijc.2750610.1002/ijc.27506 ↗
25. 10.1038/nature1136910.1038/nature11369 ↗
26. 10.1002/bit.2307110.1002/bit.23071 ↗
27. 10.1074/jbc.M40962920010.1074/jbc.M409629200 ↗
28. 10.1002/adma.20210349710.1002/adma.202103497 ↗
29. 10.1172/JCI8442710.1172/JCI84427 ↗
30. 10.1021/acsnano.8b0437110.1021/acsnano.8b04371 ↗
31. 10.1002/advs.20200333810.1002/advs.202003338 ↗
32. 10.1021/acs.nanolett.9b0402410.1021/acs.nanolett.9b04024 ↗
33. 10.1016/j.carbpol.2021.11799910.1016/j.carbpol.2021.117999 ↗
34. 10.1021/acs.nanolett.6b0253610.1021/acs.nanolett.6b02536 ↗
35. 10.1093/clinchem/42.10.158910.1093/clinchem/42.10.1589 ↗
36. 10.1021/acs.nanolett.0c0398210.1021/acs.nanolett.0c03982 ↗
37. 10.1073/pnas.161292011410.1073/pnas.1612920114 ↗
38. 10.1158/0008-5472.CAN-17-396210.1158/0008-5472.CAN-17-3962 ↗
39. 10.1038/nrclinonc.2010.15410.1038/nrclinonc.2010.154 ↗
40. 10.1073/pnas.171819711510.1073/pnas.1718197115 ↗
41. 10.1084/jem.2008217310.1084/jem.20082173 ↗
42. 10.3390/ijms2011276710.3390/ijms20112767 ↗
43. 10.2217/fon.09.9010.2217/fon.09.90 ↗